tert-Butyl piperazine-1-carboxylate → tert-Butyl 4-(5-iodopyridin-2-yl)piperazine-1-carboxylate

HRID 1851671Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1851671
F[C:2]1[CH:7]=[CH:6][C:5]([I:8])=[CH:4][N:3]=1.[C:9]([N:16]1[CH2:21][CH2:20][NH:19][CH2:18][CH2:17]1)([O:11][C:12]([CH3:15])([CH3:14])[CH3:13])=[O:10]>>[C:12]([O:11][C:9]([N:16]1[CH2:21][CH2:20][N:19]([C:2]2[CH:7]=[CH:6][C:5]([I:8])=[CH:4][N:3]=2)[CH2:18][CH2:17]1)=[O:10])([CH3:15])([CH3:13])[CH3:14]

Komponenten

3

Versuchsvorschrift

By carrying out the procedure as described in preparation 1, but using 2-fluoro-5-iodopyridine instead of 2-chloro-5-(trifluoromethyl)pyridine and N-Boc-piperazine instead of cis-2,6-dimethylpiperazine, the title compound is obtained in the form of an oil.

Aufarbeitung

  1. customas described in preparation 1

Quellen und Nachweise

ORD-Eintrag
ord-8e94fc84916d493899fc476e4a067bd8
Quelldatensatz
uspto-grants-2015_02
Patentnummer
US08957211B2

Notizen zur Reaktion

Wird geladen…